Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

H. Goldschmidt; P. Sonneveld; T.W. Cremer; B. van der Holt; I. Westveer; I. Breitkreutz; A. Benner; A. Glasmacher; I.G. Schmidt-Wolf; H. Martin; D. Hoelzer; A.D. Ho; H.M. Lokhorst

Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

Translated title of the contribution: Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

H. Goldschmidt
, P. Sonneveld
, T.W. Cremer
, B. van der Holt
, I. Westveer
, I. Breitkreutz
, A. Benner
, A. Glasmacher
, I.G. Schmidt-Wolf
, H. Martin
, D. Hoelzer
, A.D. Ho
, H.M. Lokhorst

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients
Original language	Undefined/Unknown
Pages (from-to)	654-659
Number of pages	6
Journal	Annals of Hematology
Volume	82
Publication status	Published - 2003

Cite this

Goldschmidt, H., Sonneveld, P., Cremer, T. W., van der Holt, B., Westveer, I., Breitkreutz, I., Benner, A., Glasmacher, A., Schmidt-Wolf, I. G., Martin, H., Hoelzer, D., Ho, A. D., & Lokhorst, H. M. (2003). Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Annals of Hematology, 82, 654-659.

@article{748c931f43ab4b678fe505389f01de2c,

title = "Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients",

author = "H. Goldschmidt and P. Sonneveld and T.W. Cremer and \{van der Holt\}, B. and I. Westveer and I. Breitkreutz and A. Benner and A. Glasmacher and I.G. Schmidt-Wolf and H. Martin and D. Hoelzer and A.D. Ho and H.M. Lokhorst",

year = "2003",

language = "Undefined/Unknown",

volume = "82",

pages = "654--659",

journal = "Annals of Hematology",

issn = "0939-5555",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

Goldschmidt, H, Sonneveld, P, Cremer, TW, van der Holt, B, Westveer, I, Breitkreutz, I, Benner, A, Glasmacher, A, Schmidt-Wolf, IG, Martin, H, Hoelzer, D, Ho, AD & Lokhorst, HM 2003, 'Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients', Annals of Hematology, vol. 82, pp. 654-659.

TY - JOUR

T1 - Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

AU - Goldschmidt, H.

AU - Sonneveld, P.

AU - Cremer, T.W.

AU - van der Holt, B.

AU - Westveer, I.

AU - Breitkreutz, I.

AU - Benner, A.

AU - Glasmacher, A.

AU - Schmidt-Wolf, I.G.

AU - Martin, H.

AU - Hoelzer, D.

AU - Ho, A.D.

AU - Lokhorst, H.M.

PY - 2003

Y1 - 2003

M3 - Article

SN - 0939-5555

VL - 82

SP - 654

EP - 659

JO - Annals of Hematology

JF - Annals of Hematology

ER -